$AUPH Breaking Out On Drug News

April 21, 2017
By

Relavent info-“Both doses of voclosporin at 48 weeks demonstrated continued improvement over the control group across multiple dimensions. Notably, the voclosporin groups demonstrated statistically significantly improved speed and rates of CR and PR. Of the patients that achieved CR at 24 weeks, in the low-dose voclosporin group, 100% remained in CR at 48 weeks, which demonstrates durability of clinical response. Proteinuria levels and reduction in SLEDAI scores, which include non-renal measures of lupus activity, also continued to significantly separate over time versus the control group. Additional analyses are ongoing and will be presented at future medical and scientific meetings. No unexpected safety signals were observed and voclosporin was generally well-tolerated, with the nature of adverse events consistent with what is expected of patients suffering from highly active LN while undergoing immunomodulation-based therapy.”

$NUE at support

April 18, 2017
By

$NUE at int. term support: Previous Low, Previous High, 200ma, 50% ret., also lower BB Daily and Weekly.

Note: Earnings Thursday  4/20 before the open.

 

 

$WFC great r/r under 52

April 13, 2017
By

50% retracement, 200ma, very oversold short and int. term:

$AMGN 200ma setup

April 10, 2017
By

Looking at $AMGN after gap fill, basing on 200ma. Earn 4/26:

 

$SRNA – $IMLFF analogy

April 7, 2017
By

$IMLFF: Cannabis Rocketship

April 6, 2017
By

Got a runner in $IMLFF, targets: .76, .96

Quick Reference Videos

Click on links below for an Introduction to Dan's Mentoring Group and a Recent Advance Class Meeting -

btm022613

btm021213b

bmt2_8